IPCA LABORATORIES
Back to Balance Sheet
|
IPCA LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹224 Cr | ₹278 Cr | ₹306 Cr | ₹186 Cr | ₹162 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of IPCA LABORATORIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹224 Cr |
| Mar2025 | ₹278 Cr |
| Mar2024 | ₹306 Cr |
| Mar2023 | ₹186 Cr |
| Mar2022 | ₹162 Cr |
How is Deferred Tax Assets / Liabilities of IPCA LABORATORIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹224 Cr | -19.32 | |
| Mar2025 | ₹278 Cr | -9.21 | |
| Mar2024 | ₹306 Cr | 65.01 | |
| Mar2023 | ₹186 Cr | 14.31 | |
| Mar2022 | ₹162 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹47,945.5 Cr | 7.7% | -1.1% | 25.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹450,211.0 Cr | -3% | -2.6% | 21.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹228,303.0 Cr | -0.5% | 17% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 0.6% | 2.7% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,672.0 Cr | -2.2% | 0.8% | -2.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,533.5 Cr | -1.1% | -1.6% | -0.8% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | 7.7% |
-1.1% |
25.2% |
| SENSEX | -1.2% |
-1.2% |
-3.3% |
You may also like the below Video Courses